Author

Anne Catharina Dressler

Observed names: A. C. Dressler, Anne Dressler, Anne-Catharina Dressler, Anne-Catharine Dressler, Dressler, Anne Catharina

Observed institutions: Fox Chase Cancer Center, University of Vienna, Good Samaritan Hospital, Memorial Sloan Kettering Cancer Center, University of Iceland, Georgetown University, QIMR Berghofer Medical Research Institute, University of Cambridge, Comprehensive Cancer Center Vienna, Centre Léon Bérard, Beckman Research Institute, Medical University of Vienna, University of Pennsylvania

OpenAlex ID: A5109335367

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2010 · Antonis C. Antoniou, Jonathan Beesley, et al. · Cancer Research · 176

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

2011 · Antonis C Antoniou, Christiana Kartsonaki, et al. · Human Molecular Genetics · 76

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

2011 · David G. Cox, Jacques Simard, et al. · Human Molecular Genetics · 44

Accuracy of Preoperative Vulva Biopsy and the Outcome of Surgery in Vulvar Intraepithelial Neoplasia 2 and 3

2009 · Stephan Polterauer, Anne Catharina Dressler, et al. · International Journal of Gynecological Pathology · 32

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers

2010 · Logan C Walker, Zachary S Fredericksen, et al. · Breast Cancer Research · 29

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2020 · Noguchi, Tetsuro, Caldes, Trinidad, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 19

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

2011 · Amanda B. Spurdle, Louise Marquart, et al. · Cancer Epidemiology Biomarkers & Prevention · 18

A Cross-Sectional Study of Patients’ Satisfaction With Totally Implanted Access Ports

2016 · Christoph Minichsdorfer, Thorsten Füreder, et al. · Clinical journal of oncology nursing · 16

Response Prediction to Neoadjuvant Chemotherapy: Comparison between Pre-Therapeutic Gene Expression Profiles and In Vitro Chemosensitivity Assay

2013 · Christian F. Singer, Florian Klinglmüller, et al. · PLoS ONE · 12

Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations

2013 · Anne Catharina Dressler, Gernot Hudelist, et al. · Journal of Cancer Research and Clinical Oncology · 6

Response prediction to neoadjuvant chemotherapy: Comparison between pretherapeutic gene expression profiles and in vitro chemosensitivity assay.

2010 · C. F. Singer, F. Klinglmüller, et al. · Journal of Clinical Oncology · 1

Supplementary Methods, Tables 1-3, Figure 1 from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2023 · Antonis C. Antoniou, Jonathan Beesley, et al.

Supplementary Methods, Tables 1-3, Figure 1 from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2023 · Antonis C. Antoniou, Jonathan Beesley, et al.

Data from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2023 · Antonis C. Antoniou, Jonathan Beesley, et al.

Data from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

2023 · Antonis C. Antoniou, Jonathan Beesley, et al.

Works count: 16

Citation count: 429

H-index: 9

I10-index: 9